Delivery Order SPE2DB20D3103-SPE2DB23FM5X0
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The firm-fixed price Delivery Order contract, valued at $1,464.64, was awarded by the Defense Agency Defense Logistics Agency Troop Support Medical on May 6, 2024 with a completion date of May 7, 2024. This award is not set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $2,620.70 Firm Fixed Price Delivery Order for the supply of 4563337065 LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract, awarded by the Defense Logistics Agency (DLA), has a performance period ending on January 17, 2024. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense...
- This federal contract award is a delivery order (SPE2DB21FP6Z9) valued at $3,743.88 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $4,831.88 Firm Fixed Price Delivery Order for Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of December 2, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The ceiling value of the delivery order is $1,722.46, and it has an ultimate completion date of July 31, 2024. This contract is not set aside for any special program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a delivery order for the pharmaceutical product Lantus Solostar 100 Unit/ML 3ML. The contract, valued at $2,603.84, was awarded by the Defense Logistics Agency (DLA) and has a completion date of September 8, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a $4,832.40 firm fixed-price delivery order placed by the Defense Logistics Agency (DLA) for the pharmaceutical product Lantus Solostar 100 unit/mL 3mL. The contract has an ultimate completion date of May 18, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of...
- This federal contract award, valued at $1,187.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a critical insulin medication. It is a delivery order awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order, valued at $1,289.74, is for the provision of Lantus SoloSTAR 100 unit/mL 3mL, a specialty pharmaceutical product. The contract is a firm fixed price delivery order that does not have a set-aside designation....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,923.56 firm fixed price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication. The award has a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM5X0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,529.04 firm fixed-price delivery order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,529.04 and an ultimate completion date of February 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable the efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 2/27/23 |